Their study found a higher percentage of CD8+ Tregs (defined as CD8+ CD25+ FOXP3+ CD28− CTLA-4+) in OC patients compared with benign ovarian tumour patients and healthy controls. This evidence concerns the gene CD8A and ovarian benign neoplasm.